Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
AssigneeNuvo Research Inc.
InventorsMathias Brosz, Friedrich Wilhelm Kuhne, Klaus Blaszkiewitz, Thomas Isensee
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating or inhibiting at least one of allergic asthma, allergic rhinitis and atopic dermatitis, or of reducing, inhibiting or treating allergy like symptoms. The methods use compositions comprising chlorite, chloride, chlorate and/or sulfate ions.
Claims32
A method of reducing, inhibiting or treating allergy-like symptoms in a subject suffering from or at risk of developing at least one of allergic asthma, allergic rhinitis and atopic dermatitis, the method comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising chlorite ions wherein the allergy-like symptoms comprise conjunctivitis, and wherein the administering is effected not more than once every six months, once every year, or once every two years.
The method of claim l, wherein the subject is at risk of developing at least one of the allergic asthma rhinitis and atopic dermatitis.
The method of claim l, wherein the subject is symptom-free of conjunctivitis symptoms.
Dependencies are inferred from the claim text.